Although shifts in the geopolitical landscape affected the Swiss life sciences industry in 2022, it resisted a major downturn in terms of private equity funding. Swiss biotech companies raised a total of USD 590 million in venture capital in 36 financing rounds. This is less than in the previous three years, but matches pre-COVID 19 … Continue reading Switzerland Life Science Trend Analysis 2023
Category: Life Sciences Reports
This area includes the yearly life sciences and Biotech reports with statistics retrieved from Biotechgate.
Netherlands Life Science Trend Analysis 2023: A Difficult Year for Venture Financing
Tuesday, 04 July 2023 Biotechgate, the leading global biotech database, published their annual Trend Analysis Report 2023 of the Dutch life sciences sector. In 2022, compared to 2021, venture financing of life science and biotech companies went down by more than 50%. Furthermore, the year-to-year growth rate of new biotech ventures has been decreasing since 2018, with … Continue reading Netherlands Life Science Trend Analysis 2023: A Difficult Year for Venture Financing
Maryland Life Science Trend Analysis 2023
Maryland’s life science private equity investment landscape in 2022 shifted back to levels seen prior to the exceptional growth experienced in 2021. The total value of life science venture financing in Maryland dropped from USD 1.2 billion in 2021 to half that amount in 2022, with USD 558 million invested. Looking at the top venture … Continue reading Maryland Life Science Trend Analysis 2023
France Life Science Trend Analysis 2023
The Healthcare Innovation 2030 strategy, launched in 2021 and supported with USD 7.9 billion, aims to establish France as a European leader in the life sciences industry by promoting innovation and growth. One year on, this plan appears to be on track: Despite uncertain market conditions and unlike most other European countries, France was able … Continue reading France Life Science Trend Analysis 2023
Canada Life Science Trend Analysis 2023
Canadian biotech private equity investment has grown steadily over the past four years, but appears to have hit its peak in 2021 – in 2022, the value of biotech equity financings failed to match the record levels of the previous year (2022: USD 599 million vs. 2021: USD 841 million). Ontario is Canada’s most active … Continue reading Canada Life Science Trend Analysis 2023
UK Life Science Trend Analysis 2023
As one of the world’s top players in life sciences, the UK boasts a strong biotech sector, which accounts for 30% of the total UK life sciences industry. While half of biotech companies are primarily involved in R&D services, more than a third are therapeutics and diagnostics companies, and the remaining 15% are other biotechs … Continue reading UK Life Science Trend Analysis 2023
Germany Life Science Trend Analysis 2023
After two strong years driven by the global pandemic, the German life sciences industry did not perform as well in terms of equity investment in 2022. As Biotechgate data shows, venture investment in biotech companies fell by almost half as compared to 2021, and with only USD 419 million in equity funding, is at its … Continue reading Germany Life Science Trend Analysis 2023
Taiwan Life Science Trend Analysis 2023
The biotech industry is one of Taiwan’s key industries that the Taiwanese government is actively promoting with the aim of strengthening international partnerships and growing export services. According to Biotechgate data, biotech companies account for 41% (263) of the total 640 life science companies in Taiwan. As for most other countries, the pandemic boosted the … Continue reading Taiwan Life Science Trend Analysis 2023
South Korea Life Science Trend Analysis 2022
In 2021, biotech companies account for 44% of the life sciences companies in South Korea. More than half of South Korean biotechs are part of the therapeutics and diagnostics sector, of which 19% are publicly listed on the stock exchange. The total value of venture financing for South Korean life sciences companies dropped by around … Continue reading South Korea Life Science Trend Analysis 2022
Maryland Life Science Trend Analysis 2022
The life science industry in Maryland shows an upward trend in 2021, with an increase of 41% in private equity investment value of life science companies compared to the previous year. While there were 11 private equity rounds of biotech companies with a total investment of USD 302 million in 2020, the number of rounds … Continue reading Maryland Life Science Trend Analysis 2022